PE/Cyanine7 anti-human CD38 Antibody
- 产品名称：
- PE/Cyanine7 anti-human CD38 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 303515
- 产品应用：
- 303515
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1836 |
1 |
- Verified Reactivity
- Human
- Reported Reactivity
- Chimpanzee, Horse, Cow
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections6?and spatial biology (IBEX)10,11.
- Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Kishimoto T, et al. Eds. 1997. Leucocyte Typing VI. Garland Publishing Inc. London.
- Dieu M. 1998. J. Exp. Med. 188:373.
- Esser M, et al. 2001. J. Virol. 75:6173.
- Jeannin P, et al. 1999. J. Immunol. 162:2044.
- Kapsogeorgou EK, et al. 2001. J. Immunol. 166:3107.
- van der Voort R, et al. 1997. J. Exp. Med. 185:2121. (IHC)
- Bende RJ, et al. 2003. Am. J. Pathol. 162:105.
- Lehner M, et al. 2008. J. Leukoc. Biol. 83:883. PubMed
- Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
- Radtke AJ,?et al. 2020.?Proc Natl Acad Sci USA. 117:33455-33465. (SB)?PubMed
- Radtke AJ,?et al. 2022.?Nat Protoc. 17:378-401. (SB)?PubMed
- Product Citations
-
- Tavor S, et al. 2020. Haematologica. . PubMed
- Fu J et al. 2019. Cell stem cell. 24(2):227-239 . PubMed
- Shoda H, et al. 2017. Arthritis Research & Therapy . 10.1186/s13075-017-1308-y. PubMed
- Karim F, et al. 2021. Elife. 10:. PubMed
- Ishizaka A, et al. 2016. J Virol. 90: 5665 - 5676. PubMed
- Nagafuchi Y, et al. 2016. Sci Rep. 6:29338. PubMed
- Tsuchida Y, et al. 2017. PLoS One. 10.1371/journal.pone.0169646. PubMed
- Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
- Chaimowitz N, et al. 2011. J Immunol. 187:5114. PubMed
- Turner JS, et al. 2021. Nature. 596:109. PubMed
- Boisson B, et al. 2015. J Exp Med. 212:939. PubMed
- Lal A, et al. 2021. Nat Commun. 1507:12. PubMed
- Huang M, et al. 2021. BMC Infect Dis. 21:922. PubMed
- Albayrak E, et al. 2021. J Cell Physiol. 236:8122. PubMed
- Amanat F, et al. 2021. Cell. 184:3936. PubMed
- , et al. 2020. Haematologica. 105:2795. PubMed
- Wang X, et al. 2021. Cell Discovery. 7(1):60. PubMed
- Hofmann M, et al. 2012. Leukemia. 26:1288. PubMed
- Turner JS, et al. 2020. Nature. 586:127. PubMed
- Okurut S, et al. 2020. Infect Immun. 88:. PubMed
- Audigé A, et al. 2017. BMC Immunology. 10.1186/s12865-017-0209-9. PubMed
- Isobe T, et al. 2022. Nat Commun. 13:4501. PubMed
- Hoffmann M, et al. 2016. PLoS Pathog. 12: 1005661. PubMed
- Setliff I, et al. 2018. Cell Host Microbe. 23:845. PubMed
- Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
- Fu Y, et al. 2021. Cell Reports. 36(2):109344. PubMed
- Lorkova L, et al. 2015. PLoS One. 10: 0135314. PubMed
- Singh A, et al. 2020. Cell Rep. 32:108153. PubMed
- Weinberg A, et al. 2015. PLoS One. 10:122431. PubMed
- Inui M, et al. 2015. Int Immunol. 27: 345 - 355. PubMed
- S Tzeng 2016. J Vis Exp. 118:e54582. PubMed
- Neu KE, et al. 2019. J Clin Invest. 129:93. PubMed
- Salazar-Camarena DC, et al. 2020. Sci Rep. 10:6236. PubMed
- Katsuyama E, et al. 2020. Cell Reports. 30(1):112-123.e4.. PubMed
- Bhuiyan TR, et al. 2022. PLoS Negl Trop Dis. 16:e0010411. PubMed
- Dutta AK, et al. 2019. Leukemia. 33:457. PubMed
- Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
- Chen PM, et al. 2022. Sci Adv. 8:eabo4271. PubMed
- Trivedi S, et al. 2020. Elife. 9:00. PubMed
- Shan L, et al. 2017. Immunity. 47:766. PubMed
- RRID
- AB_1279235 (BioLegend Cat. No. 303515) AB_2072782 (BioLegend Cat. No. 303516)
- Structure
- ADP-ribosyl cyclase, ectoenzyme, type II glycoprotein, 45 kD
- Distribution
-
T cells, B cells, NK, myeloid, plasma, and dendritic cells
- Function
- Ecto-ADP-ribosyl cyclase, calcium signaling, cell activation
- Ligand/Receptor
- CD31, hyaluronic acid
- Cell Type
- B cells, Dendritic cells, NK cells, Plasma cells, T cells
- Biology Area
- Immunology
- Molecular Family
- Adhesion Molecules, CD Molecules
- Antigen References
-
1. Ferrero E, et al. 1999. J. Leukoc. Biol. 65:151.
2. Lund F, et al. 1995. Immunol. Today 16:469.
- Gene ID
- 952 View all products for this Gene ID
- UniProt
- View information about CD38 on UniProt.org
